Molly Weaver PhD
Molly Weaver PhD Appointed Chief Technology Officer, Products ApiJect Systems
In her new role, Dr. Weaver will help facilitate ApiJect’s injectable platform development featuring BlowFill-Seal (BFS) technology and its initial product – a single-dose prefilled drug delivery system that is aseptically-filled, efficient to manufacture and can be produced in high volumes.